Search

everythinglearnresearchcommunity

for

Search:↓

GnRH analogue can help diagnose ovarian causes of high testosterone in postmenopausal women when scans don't show the cause.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Cyproterone acetate is effective for treating hirsutism and acne but less so for hair loss, with side effects similar to birth control pills.

Antiandrogens are effective for conditions like prostate cancer and skin issues, but more research is needed to confirm their benefits and minimize side effects.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

The document concludes that early diagnosis is key for treating common baldness in women, but reassurance is often the best approach as hair thinning can be a normal part of aging.

Spironolactone is a low-cost, effective, and generally safe treatment for various skin conditions related to hormones.

Birth control pills increase certain receptor activities in female gerbil prostate glands and can lead to prostate changes.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Recombinant gonadotropins improve future fertility in CHH patients.

The treatment successfully lowered testosterone levels and reduced symptoms.

Ac-GFFY-IGF peptide is a promising, safe, and effective treatment for hair loss, better than current options.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

New treatments for male hypogonadism are effective and should be personalized.

Most patients improved with oral contraceptives, but some needed additional treatment.

Dienogest is safer and has fewer side effects than GnRH analogues for treating endometriosis.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

GnRH analogues are effective for diagnosing and treating female androgen excess, offering a non-surgical option.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Agomelatine may help reduce benign prostatic hyperplasia by blocking certain inflammatory pathways.

Antibody treatments show promise for hair loss but need more research.

Epitestosterone may act as a weak antiandrogen and can inhibit an enzyme involved in testosterone metabolism.

New treatments for male hypogonadism are easier to use and target specific tissues to reduce side effects.

Androgenic alopecia can be treated with minoxidil, finasteride, and hormonal therapy.

ADT for prostate cancer may harm the heart, but GnRH antagonists might be safer.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.